Cellectar Biosciences Stock (NASDAQ: CLRB) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 56.99K / 518.94K |
Day Range | - - - |
52 Wk Range | 1.56 - 4.45 |
Market Cap | $94.28M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 52 |
Short Interest | 7.2% |
Days to Cover | 2.87 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Cellectar Biosciences (NASDAQ:CLRB) through any online brokerage.
Other companies in Cellectar Biosciences’s space includes: Serina Therapeutics (AMEX:SER), Anixa Biosciences (NASDAQ:ANIX), T2 Biosystems (NASDAQ:TTOO), FibroGen (NASDAQ:FGEN) and Vistagen Therapeutics (NASDAQ:VTGN).
There is no analysis for Cellectar Biosciences.
Cellectar Biosciences has a consensus price target of $14.67.
The stock price for Cellectar Biosciences (NASDAQ: CLRB) is $2.63 last updated Today at July 22, 2024 at 8:34 AM EDT.
There are no upcoming dividends for Cellectar Biosciences.
Cellectar Biosciences’s Q2 earnings are confirmed for Monday, August 12, 2024.
There is no upcoming split for Cellectar Biosciences.
Cellectar Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.